Teladoc Health announced employment inducement awards for new Chief Financial Officer Michael Grasher, effective Sept. 1, 2026. The grants include restricted stock units covering 239,616 shares and performance stock units targeting 239,616 shares, with up to 479,232 shares potentially earnable. Approved by the Compensation Committee under the company’s 2023 Employment Inducement Incentive Award Plan, the awards are subject to continued service and performance based on 2026 adjusted EBITDA and actual compound annual revenue growth from 2026 through 2028.